Cantor Fitzgerald Starts Agile Therapeutics (AGRX) at Buy

Go back to Cantor Fitzgerald Starts Agile Therapeutics (AGRX) at Buy

William Blair Starts Agile Therapeutics (AGRX) at Outperform

June 17, 2014 9:24 AM EDT

William Blair initiated coverage on Agile Therapeutics (NASDAQ: AGRX) with an Outperform rating.

For an analyst ratings summary and ratings history on Agile Therapeutics click here. For more ratings news on Agile Therapeutics click here.

Shares of Agile Therapeutics closed at $6.78 yesterday.

... More

Janney Starts Agile Therapeutics (AGRX) at Buy

June 17, 2014 7:23 AM EDT

Janney Montgomery Scott initiated coverage on Agile Therapeutics (NASDAQ: AGRX) with a Buy rating and a price target of $18.00.

For an analyst ratings summary and ratings history on Agile Therapeutics click here. For more ratings news on Agile Therapeutics click here.

Shares of Agile Therapeutics closed at $6.78 yesterday.

... More